Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients.

Wu CY, Wu MS, Kuo KN, Wang CB, Chen YJ, Lin JT.

J Clin Oncol. 2010 Jun 20;28(18):2952-7. doi: 10.1200/JCO.2009.26.0695. Epub 2010 May 17.

PMID:
20479409
2.

Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.

Wu CY, Kuo KN, Wu MS, Chen YJ, Wang CB, Lin JT.

Gastroenterology. 2009 Nov;137(5):1641-8.e1-2. doi: 10.1053/j.gastro.2009.07.060. Epub 2009 Aug 5.

PMID:
19664631
3.

The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.

Arroyo MT, Forne M, de Argila CM, Feu F, Arenas J, de la Vega J, Garrigues V, Mora F, Castro M, Bujanda L, Cosme A, Castiella A, Gisbert JP, Hervas A, Lanas A.

Helicobacter. 2004 Jun;9(3):249-54.

PMID:
15165261
4.

Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.

Xia B, Xia HH, Ma CW, Wong KW, Fung FM, Hui CK, Chan CK, Chan AO, Lai KC, Yuen MF, Wong BC.

Aliment Pharmacol Ther. 2005 Aug 1;22(3):243-9.

5.

Effect of non-steroidal anti-inflammatory drugs on gastric and duodenal prostaglandin concentrations in patients with Helicobacter pylori infection.

Tseng GY, Lin HJ, Lin HY, Perng CL, Lee FY, Lo WC, Tsay SH, Li AS, Chang FY, Lee SD.

Hepatogastroenterology. 1999 Mar-Apr;46(26):1000-4.

PMID:
10370655
6.

Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified?

Jyotheeswaran S, Shah AN, Jin HO, Potter GD, Ona FV, Chey WY.

Am J Gastroenterol. 1998 Apr;93(4):574-8.

PMID:
9576450
7.

Unanswered questions about Helicobacter pylori.

Walsh JH.

Aliment Pharmacol Ther. 1995;9 Suppl 1:31-7. Review.

PMID:
7495940
9.

Non-steroidal anti-inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer.

Ng TM, Fock KM, Khor JL, Teo EK, Sim CS, Tan AL, Machin D.

Aliment Pharmacol Ther. 2000 Feb;14(2):203-9.

10.

Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.

Russell RI.

Ital J Gastroenterol Hepatol. 1997 Oct;29(5):465-9. Review.

PMID:
9494858
11.

[Risk factor Helicobacter pylori. Prevention of stomach carcinoma].

[No authors listed]

MMW Fortschr Med. 2005 May 19;147(20):53. German. No abstract available.

PMID:
15957864
12.

Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.

Labenz J, Peitz U, Köhl H, Kaiser J, Malfertheiner P, Hackelsberger A, Börsch G.

Ital J Gastroenterol Hepatol. 1999 Mar;31(2):110-5.

PMID:
10363194
13.

Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.

Aalykke C, Lauritsen JM, Hallas J, Reinholdt S, Krogfelt K, Lauritsen K.

Gastroenterology. 1999 Jun;116(6):1305-9.

PMID:
10348813
14.

Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.

Campbell DR, Haber MM, Sheldon E, Collis C, Lukasik N, Huang B, Goldstein JL.

Am J Gastroenterol. 2002 Sep;97(9):2208-14.

PMID:
12358234
16.

Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding.

Stack WA, Atherton JC, Hawkey GM, Logan RF, Hawkey CJ.

Aliment Pharmacol Ther. 2002 Mar;16(3):497-506.

17.

Is Helicobacter pylori eradication useful in patients taking NSAIDs?

Hawkey CJ.

Eur J Gastroenterol Hepatol. 1999 Aug;11 Suppl 2:S47-50; discussion S73.

PMID:
10503823
18.

Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.

Rybár I, Masaryk P, Mateicka F, Kopecký S, Rovenský J.

Int J Clin Pharmacol Res. 2001;21(3-4):119-25.

PMID:
12067141
19.

[Peptic ulcer disease etiology, diagnosis and treatment].

Bak-Romaniszyn L, Wojtuń S, Gil J, Płaneta-Małecka I.

Pol Merkur Lekarski. 2004;17 Suppl 1:128-32. Review. Polish.

PMID:
15603370
20.

Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population.

Nishikawa K, Sugiyama T, Kato M, Ishizuka J, Komatsu Y, Kagaya H, Katagiri M, Nishikawa S, Hokari K, Takeda H, Asaka M.

Eur J Gastroenterol Hepatol. 2000 Jun;12(6):635-40.

PMID:
10912481

Supplemental Content

Support Center